GLP-1 Drug Use: High Discontinuation Rates and Potential Health Implications
GLP-1 drugs, such as Ozempic and Zepbound, are increasingly used for treating diabetes and obesity, yet many patients discontinue their use. According to Dr. Jaime Almandoz from the University of Texas Southwestern Medical Center, fewer than 25% of patients remain on these medications after a year. The reasons for discontinuation include outdated perceptions of obesity treatment, cost, insurance issues, and side effects. Despite this, a significant number of patients express intentions to restart the medication, as noted by Leigh O'Donnell from Kantar. The availability of these drugs in pill form and through online sellers without the need for doctor or insurance approvals is lowering barriers to use. However, the health effects of intermittent use remain under-researched, with concerns about rapid weight regain and muscle loss. 
